bg
T

Taysha Gene Therapies (TSHA)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Taysha Gene Therapies (TSHA)

Taysha Gene Therapies, Inc. is a patient-centric gene therapy company. The Company is focused on developing and commercializing adeno-associated virus (AAV)-based gene therapies for the treatment of monogenic diseases of the central nervous system (C... Read more

  • USD2.52
  • USD2.56
  • USD2.48
  • USD3.31
  • -1.20%
  • 7M
  • 544.22k
  • 3.47M
  • 665M
  • 1.05
  • 2.90%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.